Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07365514 · ClinicalTrials.gov registry record · Phase 1
Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis Risk in Postmenopausal Females
A Phase 1 study, sponsored by University of Connecticut.
- Not yet
- Registry status
- Phase 1
- Development phase
- 159
- Enrollment target
NCT07365514: Clinical Trial Phase 1 study, sponsored by University of Connecticut.
NCT07365514 is a Phase 1 study that has not yet begun recruiting, run by University of Connecticut. The registered enrollment target is 159 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (165% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07365514, a Phase 1 study, has not yet begun recruiting, sponsored by University of Connecticut.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 159 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to evaluate the effects of blackcurrant (BC) supplementation on changes in bone density and gut microbiome composition in postmenopausal females.
Primary Outcome
Changes from baseline in whole-body, lumbar spine, total hip and femoral neck BMD at months 6 and 12 measured via dual energy x-ray absorptiometry (DXA)
Interventions
- DRUG Placebo
- DRUG Blackcurrant (BC) extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2026-02-01 |
| Est. Completion | 2029-09 |
| Phase | Phase 1 |
What is known before NCT07365514 opens enrollment
NCT07365514 is an interventional study that assigns participants to a tested intervention. The registered 159 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (165% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07365514 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07365514 about?
NCT07365514 is a clinical study titled "Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis Risk in Postmenopausal Females". The goal of this clinical trial is to evaluate the effects of blackcurrant (BC) supplementation on changes in bone density and gut microbiome composition in postmenopausal females.
What is the current status of trial NCT07365514?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 159 participants. The study started on 2026-02-01. Estimated completion is 2029-09.
What interventions are being tested in trial NCT07365514?
The interventions under investigation include: Placebo (DRUG), Blackcurrant (BC) extract (DRUG).
Who is sponsoring clinical trial NCT07365514?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07365514's enrollment target sits among peer trials
159 346th of 2000 higher than 1,653 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05267626 · 159 participants · Phase 1
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- NCT06321575 · 159 participants · NA
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
- NCT06729151 · 159 participants
Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome
- NCT07023731 · 159 participants · Phase 1
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI